Literature DB >> 7720227

Urinary 6 beta-hydroxycortisol in humans: analysis, biological variations, and reference ranges.

C Lee1.   

Abstract

OBJECTIVE: To evaluate methods for analysis, biological variation, and reference ranges for 6 beta-hydroxycortisol in urine.
METHODS: The urinary level of 6 beta-hydroxycortisol (6 beta-OHF) was measured by reversed-phase high performance liquid chromatography.
RESULTS: The method was accurate and precise, as indicated by a recovery rate of 92-95% and less than 5.5% and 6.6% of coefficient of variation for within-run and between-run assay, respectively. The reference range of urinary 6 beta-OHF was 187-1245 nmol/day in adults (20-60 years) and 103-915 nmol/day in the elderly (> 61 years). No significant day-to-day intrabiological variation was observed in a 5-day period. Diurnal rhythms of urinary 6 beta-OHF and urinary free cortisol (UFC) were quite parallel to each other, so that the ratio of 6 beta-OHF to UFC remained constant through the day.
CONCLUSION: An early morning urine specimen can provide the urinary ratio of 6 beta-OHF to UFC as adequately as that determined from 24-h specimen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720227     DOI: 10.1016/0009-9120(94)00060-9

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

Review 1.  Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.

Authors:  Gaëlle Magliocco; Aurélien Thomas; Jules Desmeules; Youssef Daali
Journal:  Clin Pharmacokinet       Date:  2019-11       Impact factor: 6.447

2.  Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction.

Authors:  Kwee Poo Yeo; Stephen L Lowe; Ming Tung Lim; James R Voelker; Jennifer L Burkey; Stephen D Wise
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

3.  A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio.

Authors:  D W Boulton; P Arnaud; C L DeVane
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

Review 4.  Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Authors:  M M Galteau; F Shamsa
Journal:  Eur J Clin Pharmacol       Date:  2003-11-06       Impact factor: 2.953

5.  Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children.

Authors:  Blanca Sinués; Esteban Mayayo; Ana Fanlo; Esteban Mayayo; María L Bernal; Pilar Bocos; Elena Bello; Jose I Labarta; Angel Ferrández-Longás
Journal:  Eur J Clin Pharmacol       Date:  2004-09-07       Impact factor: 2.953

6.  Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β-hydroxycortisol/cortisol.

Authors:  Helena Bergström; Anna Lindahl; Anna Warnqvist; Ulf Diczfalusy; Lena Ekström; Linda Björkhem-Bergman
Journal:  Pharmacol Res Perspect       Date:  2021-12

7.  Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases.

Authors:  Ehab S Eldesoky; Sherif I Kamel; Ahlam M Farghaly; Madiha Y Bakheet; Mohsen A Hedaya; Jean-Pascal Siest
Journal:  Biomark Insights       Date:  2007-02-07

8.  Comparison of two endogenous biomarkers of CYP3A4 activity in a drug-drug interaction study between midostaurin and rifampicin.

Authors:  Catherine Dutreix; Sebastien Lorenzo; Yanfeng Wang
Journal:  Eur J Clin Pharmacol       Date:  2014-05-21       Impact factor: 2.953

9.  Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots.

Authors:  Gaëlle Magliocco; Jules Desmeules; Caroline Flora Samer; Aurélien Thomas; Youssef Daali
Journal:  Clin Transl Sci       Date:  2022-03-26       Impact factor: 4.438

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.